JSM 2005 - Toronto

Abstract #303898

This is the preliminary program for the 2005 Joint Statistical Meetings in Minneapolis, Minnesota. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2005); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.



The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.


The Program has labeled the meeting rooms with "letters" preceding the name of the room, designating in which facility the room is located:

Minneapolis Convention Center = “MCC” Hilton Minneapolis Hotel = “H” Hyatt Regency Minneapolis = “HY”

Back to main JSM 2005 Program page



Legend: = Applied Session, = Theme Session, = Presenter
Activity Number: 192
Type: Contributed
Date/Time: Monday, August 8, 2005 : 2:00 PM to 3:50 PM
Sponsor: Biopharmaceutical Section
Abstract - #303898
Title: Bootstrap Confidence Intervals for Probability of Better Outcome
Author(s): Haitao Gao*+
Companies: Eli Lilly and Company
Address: Drop Code 6161, Indianapolis, IN, 46285, United States
Keywords: Bootstrap confidence intervals ; area under ROC curve ; simulations ; probability of better outcome
Abstract:

In a randomized placebo-controlled clinical trial setting with continuous efficacy measures, the treatment effect often is assessed by comparing mean change from baseline to endpoint between treatment groups. Clinicians often are more interested in the proportion of patients responding than the mean score for a group of patients. Faraone et al. (2000) proposed a drug-placebo response curve approach to address clinical significance. The approach is a generalization of the receiver operating characteristic (ROC) curve. The area under the response curve estimates the probability that a randomly selected patient given the drug will respond better than a randomly selected patient given placebo. This may have a special appeal to clinicians. Under normality assumptions, the probability can be converted to the effect size (standardized treatment difference) and vice versa. This paper examines bootstrap methods for constructing confidence intervals for the probability of better outcome. Simulations were conducted to examine both the power and Type-I error of the approach under different distributional assumptions. This method was applied to ADHD clinical trial data for illustration.


  • The address information is for the authors that have a + after their name.
  • Authors who are presenting talks have a * after their name.

Back to the full JSM 2005 program

JSM 2005 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2005